Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00005856 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

59

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma

Interventions

DRUG: oxaliplatin
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)